Grant Skrepnek to Iron Chelating Agents
This is a "connection" page, showing publications Grant Skrepnek has written about Iron Chelating Agents.
Connection Strength
0.103
-
Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs. J Med Econ. 2013; 16(1):10-8.
Score: 0.103